A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumorsJohn Goulding(Fate Therapeutics (United States)), Bahram Valamehr(Fate Therapeutics (United States))MedMay 11, 202310.1016/j.medj.2023.04.004Cited by 25SaveCiteExport RISWatch citationsRelated PapersiPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumors|Cell Reports Medicine|2025|3